Beacon Financial Advisory LLC Abb Vie Inc. Transaction History

Beacon Financial Advisory LLC

$270 Million
Q3 2024

A detailed history of Beacon Financial Advisory LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Beacon Financial Advisory LLC holds 8,368 shares of ABBV stock, worth $1.43 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

8,368

Previous 8,211 1.91%

Holding current value

$1.43 Million

Previous $1.41 Million 17.33%

% of portfolio

0.61%

Previous 0.57%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$163.84 - $199.33 $25,722 - $31,294	157 Added 1.91%	8,368 $1.65 Million
Q2 2024 Jul 26, 2024	BUY	$154.79 - $180.76 $110,365 - $128,881	713 Added 9.51%	8,211 $1.41 Million
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $1,758 - $2,003	-11 Reduced 0.15%	7,498 $1.37 Million
Q4 2023 Jan 23, 2024	BUY	$137.6 - $154.97 $825 - $929	6 Added 0.08%	7,509 $1.16 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $33,397 - $38,662	250 Added 3.45%	7,503 $1.12 Million
Q2 2023 Jul 17, 2023	BUY	$132.51 - $164.9 $2,120 - $2,638	16 Added 0.22%	7,253 $977,000
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $31,091 - $35,806	215 Added 3.06%	7,237 $1.15 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $5,809 - $6,966	-42 Reduced 0.59%	7,022 $0
Q3 2022 Oct 21, 2022	SELL	$134.21 - $153.93 $447,590 - $513,356	-3,335 Reduced 32.07%	7,064 $948,000
Q2 2022 Jul 25, 2022	BUY	$137.62 - $174.96 $48,579 - $61,760	353 Added 3.51%	10,399 $1.59 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $16,233 - $20,141	-123 Reduced 1.21%	10,046 $1.63 Million
Q4 2021 Jan 21, 2022	SELL	$107.43 - $135.93 $9,668 - $12,233	-90 Reduced 0.88%	10,169 $1.38 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $298,877 - $339,271	2,809 Added 37.7%	10,259 $1.11 Million
Q2 2021 Jul 14, 2021	BUY	$105.21 - $117.21 $12,414 - $13,830	118 Added 1.61%	7,450 $839,000
Q1 2021 Apr 20, 2021	SELL	$102.3 - $112.62 $285,621 - $314,435	-2,792 Reduced 27.58%	7,332 $794,000
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $80,007 - $108,017	994 Added 10.89%	10,124 $1.08 Million
Q3 2020 Oct 08, 2020	SELL	$85.91 - $100.83 $236,596 - $277,685	-2,754 Reduced 23.17%	9,130 $799,000
Q2 2020 Jul 07, 2020	BUY	$73.37 - $98.18 $15,774 - $21,108	215 Added 1.84%	11,884 $1.17 Million
Q1 2020 Apr 15, 2020	SELL	$64.5 - $97.79 $288,057 - $436,730	-4,466 Reduced 27.68%	11,669 $889,000
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $1.16 Million - $1.46 Million	16,135 New	16,135 $1.43 Million

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Financial Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Financial Advisory LLC with notifications on news.

Account

Beacon Financial Advisory LLC Abb Vie Inc. Transaction History